I M Appel1, B Grimminck, J Geerts, R Stigter, M H Cnossen, A Beishuizen. 1. Paediatric Haematology, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam Laboratory of Paediatric Haemostasis, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands.
Abstract
BACKGROUND: Use of age-adjusted reference values is crucial for correct diagnosis and management of thrombotic and hemorrhagic disease in children. They vary with utilized reagents and analyzers. OBJECTIVES: We established reference values with the Sysmex CA-1500 System and in parallel with the Behring BCS System using reagents from Siemens Healthcare Diagnostics Products GmbH. METHODS: After informed consent, blood samples were obtained from 218 healthy children and 52 healthy adults, grouped as 1-6 months (n = 29), 7-12 months (n = 25), 1-5 years (n = 57), 6-10 years (n = 57), 11-18 years (n = 50) and > 19 years (n = 52). RESULTS: Most coagulation parameters demonstrate good comparability between analyzers with the exception of PT and APTT. Single coagulation factors fibrinogen, factor (F) II, FIX, FXI and XII were significantly decreased in the youngest children; the strongest age dependency was found for coagulation inhibitors Protein C and S, both significantly decreased in infancy and young childhood. We confirmed that high levels of von Willebrand factor are found in the youngest children without increased levels of FVIII followed by decreased von Willebrand levels in the subsequent age group. In children with blood group O a less distinct increase in time was found, compared with individuals with one of the other blood groups. CONCLUSIONS: The correlation between the CA-1500 and the BCS system was remarkable. Differences were most pronounced between children < 12 months and older children and adults, confirming the phenomenon of developmental hemostasis. The rationale for age-related changes in the hemostatic system remains unraveled. Our results underline the need for age-specific reference ranges.
BACKGROUND: Use of age-adjusted reference values is crucial for correct diagnosis and management of thrombotic and hemorrhagic disease in children. They vary with utilized reagents and analyzers. OBJECTIVES: We established reference values with the Sysmex CA-1500 System and in parallel with the Behring BCS System using reagents from Siemens Healthcare Diagnostics Products GmbH. METHODS: After informed consent, blood samples were obtained from 218 healthy children and 52 healthy adults, grouped as 1-6 months (n = 29), 7-12 months (n = 25), 1-5 years (n = 57), 6-10 years (n = 57), 11-18 years (n = 50) and > 19 years (n = 52). RESULTS: Most coagulation parameters demonstrate good comparability between analyzers with the exception of PT and APTT. Single coagulation factors fibrinogen, factor (F) II, FIX, FXI and XII were significantly decreased in the youngest children; the strongest age dependency was found for coagulation inhibitors Protein C and S, both significantly decreased in infancy and young childhood. We confirmed that high levels of von Willebrand factor are found in the youngest children without increased levels of FVIII followed by decreased von Willebrand levels in the subsequent age group. In children with blood group O a less distinct increase in time was found, compared with individuals with one of the other blood groups. CONCLUSIONS: The correlation between the CA-1500 and the BCS system was remarkable. Differences were most pronounced between children < 12 months and older children and adults, confirming the phenomenon of developmental hemostasis. The rationale for age-related changes in the hemostatic system remains unraveled. Our results underline the need for age-specific reference ranges.
Authors: Sravya Kattula; Yaqiu Sang; Gustaaf de Ridder; Anna C Silver; Emma G Bouck; Brian C Cooley; Alisa S Wolberg Journal: J Thromb Haemost Date: 2021-09-06 Impact factor: 5.824
Authors: Adriana Weinberg; Mark J Giganti; Patricia A Sirois; Grace Montepiedra; Jennifer Canniff; Allison Agwu; Michael J Boivin; Suad Kapetanovic; Mark J Abzug Journal: AIDS Date: 2022-04-19 Impact factor: 4.632
Authors: Julie C Leonard; Cassandra D Josephson; James F Luther; Stephen R Wisniewski; Christine Allen; Fabrizio Chiusolo; Adrienne L Davis; Robert A Finkelstein; Julie C Fitzgerald; Barbara A Gaines; Susan M Goobie; Sheila J Hanson; Hilary A Hewes; Laurie H Johnson; Mark O McCollum; Jennifer A Muszynski; Alison B Nair; Robert B Rosenberg; Thomas M Rouse; Athina Sikavitsas; Marcy N Singleton; Marie E Steiner; Jeffrey S Upperman; Adam M Vogel; Hale Wills; Margaret K Winkler; Philip C Spinella Journal: Crit Care Med Date: 2021-11-01 Impact factor: 9.296
Authors: Niina Lietzén; Lu Cheng; Robert Moulder; Heli Siljander; Essi Laajala; Taina Härkönen; Aleksandr Peet; Aki Vehtari; Vallo Tillmann; Mikael Knip; Harri Lähdesmäki; Riitta Lahesmaa Journal: Sci Rep Date: 2018-04-12 Impact factor: 4.379
Authors: Hugo Maas; Savion Gropper; Fenglei Huang; Joachim Stangier; Igor Tartakovsky; Martina Brueckmann; Jacqueline M L Halton; Lesley G Mitchell Journal: Thromb Haemost Date: 2018-08-15 Impact factor: 5.249
Authors: Fabian B Fahlbusch; Thomas Heinlein; Manfred Rauh; Sven Dittrich; Robert Cesnjevar; Julia Moosmann; Jennifer Nadal; Matthias Schmid; Frank Muench; Michael Schroth; Wolfgang Rascher; Hans-Georg Topf Journal: PLoS One Date: 2018-07-10 Impact factor: 3.240